OLMA

Olema Pharmaceuticals, Inc.NASDAQHealthcare

$15.06-0.40%ClosedMarket Cap: $1.31B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-18	JP Morgan	—	Overweight	—
2026-03-18	Goldman Sachs	—	Buy	—
2026-03-17	Guggenheim	—	Buy	—
2026-03-17	Citigroup	—	Buy	—
2026-03-09	HC Wainwright & Co.	—	Buy	—
2025-12-12	Citigroup	—	Buy	—
2025-12-11	Oppenheimer	—	Outperform	—
2025-12-11	Goldman Sachs	—	Buy	—
2025-12-11	HC Wainwright & Co.	—	Buy	—
2025-11-18	JP Morgan	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-2.47	$25.4M	7
Sun Dec 31	$-1.93	$125.9M	4
Mon Dec 31	$-0.94	$303.8M	2
Tue Dec 31	$0.58	$551.4M	2